Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.
- DOI
- 10.1038/srep15150
- Published
- 2015 Oct 19
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/srep15150,
title = {Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.},
author = {Miller MA and Moss ML and Powell G and Petrovich R and Edwards L and Meyer AS and Griffith LG and Lauffenburger DA},
year = {2015},
journal = {Scientific reports},
doi = {10.1038/srep15150},
url = {https://doi.org/10.1038/srep15150}
}RIS
TY - JOUR TI - Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain. AU - Miller MA AU - Moss ML AU - Powell G AU - Petrovich R AU - Edwards L AU - Meyer AS AU - Griffith LG AU - Lauffenburger DA PY - 2015 JO - Scientific reports DO - 10.1038/srep15150 UR - https://doi.org/10.1038/srep15150 ER -
APA
MA, M., ML, M., G, P., R, P., L, E., AS, M., LG, G., & DA, L. (2015). Targeting autocrine HB-EGF signaling with specific ADAM12 inhibition using recombinant ADAM12 prodomain.. Scientific reports. https://doi.org/10.1038/srep15150
Source records
- pubmed · retrieved 2026-09-26T18:33:01.474Z